Advances in rare disease treatments and clinical trial tools demand new regulatory frameworks, former commissioners said a Schaeffer Center conference on FDA reform. The post Former FDA Leaders Say New Policies Needed to Boost Medical Innovation appeared first on USC Schaeffer.
